RPS11 and glioblastoma: However, we found that RPS11 was the only one of the 3 biomarkers where an upregulated gene expression profile (determined by Probe Set Analyzer) was completely concordant with increased protein expression in terms of increasing the hazard of death for newly diagnosed GBM (Table 3).